These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 23679894)

  • 1. Urinary profile of catecholamines and metabolites in Parkinson patients with deep brain stimulation.
    Guimarães J; Vieira-Coelho MA; Moura E; Afonso J; Rosas MJ; Vaz R; Garrett C
    Eur J Neurol; 2014 Feb; 21(2):353-6. PubMed ID: 23679894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The subthalamic activity and striatal monoamine are modulated by subthalamic stimulation.
    Yamamoto T; Uchiyama T; Sakakibara R; Taniguchi J; Kuwabara S
    Neuroscience; 2014 Feb; 259():43-52. PubMed ID: 24291727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of subthalamic nucleus deep brain stimulation and L-DOPA on blinking in Parkinson's disease.
    Bologna M; Fasano A; Modugno N; Fabbrini G; Berardelli A
    Exp Neurol; 2012 May; 235(1):265-72. PubMed ID: 22366535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of deep brain stimulation and levodopa on sensory signs in Parkinson's disease.
    Gierthmühlen J; Arning P; Binder A; Herzog J; Deuschl G; Wasner G; Baron R
    Mov Disord; 2010 Jul; 25(9):1195-202. PubMed ID: 20629160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrode position determined by fused images of preoperative and postoperative magnetic resonance imaging and surgical outcome after subthalamic nucleus deep brain stimulation.
    Paek SH; Han JH; Lee JY; Kim C; Jeon BS; Kim DG
    Neurosurgery; 2008 Nov; 63(5):925-36; discussion 936-7. PubMed ID: 19005383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic microdialysis of the basal ganglia in Parkinson's disease.
    Zsigmond P; Dernroth N; Kullman A; Augustinsson LE; Dizdar N
    J Neurosci Methods; 2012 May; 207(1):17-22. PubMed ID: 22450238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.
    Anderson VC; Burchiel KJ; Hogarth P; Favre J; Hammerstad JP
    Arch Neurol; 2005 Apr; 62(4):554-60. PubMed ID: 15824252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subthalamic nucleus stimulation does not cause deterioration of preexisting hallucinations in Parkinson's disease patients.
    Yoshida F; Miyagi Y; Kishimoto J; Morioka T; Murakami N; Hashiguchi K; Samura K; Sakae N; Yamasaki R; Kawaguchi M; Sasaki T
    Stereotact Funct Neurosurg; 2009; 87(1):45-9. PubMed ID: 19174620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease.
    Funkiewiez A; Ardouin C; Krack P; Fraix V; Van Blercom N; Xie J; Moro E; Benabid AL; Pollak P
    Mov Disord; 2003 May; 18(5):524-30. PubMed ID: 12722166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of young onset Parkinson's disease after subthalamic stimulation--a cross-sectional study.
    Tsai ST; Hung HY; Hsieh TC; Lin SH; Lin SZ; Chen SY
    Clin Neurol Neurosurg; 2013 Oct; 115(10):2082-7. PubMed ID: 23916724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central pain modulation after subthalamic nucleus stimulation: A crossover randomized trial.
    Marques A; Chassin O; Morand D; Pereira B; Debilly B; Derost P; Ulla M; Lemaire JJ; Durif F
    Neurology; 2013 Aug; 81(7):633-40. PubMed ID: 23864314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subthalamic local field potentials after seven-year deep brain stimulation in Parkinson's disease.
    Giannicola G; Rosa M; Servello D; Menghetti C; Carrabba G; Pacchetti C; Zangaglia R; Cogiamanian F; Scelzo E; Marceglia S; Rossi L; Priori A
    Exp Neurol; 2012 Oct; 237(2):312-7. PubMed ID: 22735488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial.
    Odekerken VJ; van Laar T; Staal MJ; Mosch A; Hoffmann CF; Nijssen PC; Beute GN; van Vugt JP; Lenders MW; Contarino MF; Mink MS; Bour LJ; van den Munckhof P; Schmand BA; de Haan RJ; Schuurman PR; de Bie RM
    Lancet Neurol; 2013 Jan; 12(1):37-44. PubMed ID: 23168021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep brain stimulation of the subthalamic nucleus affects resting EEG and visual evoked potentials in Parkinson's disease.
    Jech R; Růzicka E; Urgosík D; Serranová T; Volfová M; Nováková O; Roth J; Dusek P; Mecír P
    Clin Neurophysiol; 2006 May; 117(5):1017-28. PubMed ID: 16516544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep brain stimulation of the subthalamic nucleus improves pain in Parkinson's disease.
    Pellaprat J; Ory-Magne F; Canivet C; Simonetta-Moreau M; Lotterie JA; Radji F; Arbus C; Gerdelat A; Chaynes P; Brefel-Courbon C
    Parkinsonism Relat Disord; 2014 Jun; 20(6):662-4. PubMed ID: 24685343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apraxia of eyelid opening after subthalamic deep brain stimulation may be caused by reduction of levodopa.
    Umemura A; Toyoda T; Yamamoto K; Oka Y; Ishii F; Yamada K
    Parkinsonism Relat Disord; 2008 Dec; 14(8):655-7. PubMed ID: 18316231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of subthalamic deep brain stimulation versus levodopa on motor perseverations in Parkinson's disease.
    Herzog J; Möller B; Witt K; Pinsker MO; Deuschl G; Volkmann J
    Mov Disord; 2009 Jun; 24(8):1206-10. PubMed ID: 19412937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors of subthalamic stimulation in Parkinson's disease: a comparative study between short- and long-term effects.
    Tsai ST; Lin SH; Chou YC; Pan YH; Hung HY; Li CW; Lin SZ; Chen SY
    Stereotact Funct Neurosurg; 2009; 87(4):241-8. PubMed ID: 19556833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.